Aura Biosciences, Inc.
corporate_fare Company Profile
Aura Biosciences, Inc. (NASDAQ:AURA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for AURA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Aura Biosciences' Phase 3 CoMpass Trial Enrollment Nears Completion Amid Accelerated Screening
- Aura Biosciences Proposes Public Offering of Common Stock and Warrants
- Aura Biosciences Details $69.9M Offering with Strong Insider Backing Amidst Going Concern Warning
- Aura Biosciences Faces Going Concern Doubt Despite Recent Capital Raises and Clinical Progress
- Aura Biosciences Accelerates Phase 3 Enrollment, Confirms Key Clinical Data Timelines
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$106.19M
Diluted EPS
-$1.76
Op. Cash Flow
-$84.74M
Free Cash Flow
-$85.19M
Operating Income
-$112.79M
Cash & Equivalents
$59.52M
Debt / Equity
0.00×
Shares Outstanding
63.59M sh
Source: 10-K · filed 2026-03-30 · accession 0001193125-26-130401
show_chartPrice Chart
Loading chart...
feed AURA - Filings & News (Page 2)
AURA
May 04, 2026, 6:03 AM EDT
Price at Filing:
$7.11
Real-time Price:
$6.77
Change:
-$0.340 (-5%)
Market Cap:
$714.99M
AURA
May 04, 2026, 6:03 AM EDT
Price at Filing:
$6.61
Real-time Price:
$6.77
Change:
+$0.160 (+2%)
Market Cap:
$714.99M
AURA
Apr 20, 2026, 4:05 PM EDT
Price at Filing:
$7.05
Real-time Price:
$6.77
Change:
-$0.280 (-4%)
Market Cap:
$714.99M
AURA
Mar 30, 2026, 7:15 AM EDT
Price at Filing:
$6.27
Real-time Price:
$6.77
Change:
+$0.500 (+8%)
Market Cap:
$714.99M
AURA
Mar 30, 2026, 7:05 AM EDT
Price at Filing:
$6.27
Real-time Price:
$6.77
Change:
+$0.500 (+8%)
Market Cap:
$714.99M